Prashanti Cancer Care Mission

What Prashanti Cancer Care Mission does

Prashanti Cancer Care Mission (PCCM) is a registered non-profit NGO established in 1995 in Pune, India, providing comprehensive breast cancer care to underprivileged patients at no cost. Its service stack spans community awareness and screening camps (16,000+ talks and 10,000+ screenings delivered), free diagnostics (3D tomosynthesis mammography, VABB, automated breast volume scanning at the Orchids Breast Health Center — Pune's first standalone breast cancer clinic, est. 2009), and complete treatment pathways including oncoplastic surgery, chemotherapy, radiation, and pharmacy. PCCM has treated 50,000+ patients and performed 2,000+ oncoplastic surgeries, many led by founder Dr. C.B. Koppiker.

PCCM operates as an integrated ecosystem rather than a single service line: a Genetic Clinic (est. 2017) provides free counseling and subsidized testing, a Pink Ribbon Support Group (5,000+ members, est. 2009) provides psychosocial and food-bank support to 6,500+ beneficiaries, and the Center for Translational Cancer Research (CTCR, est. 2018) — a public-private partnership with IISER Pune and Bajaj Auto — runs India's first specialized breast biobank (1,625+ FFPE samples, 100+ Fresh Frozen samples) supporting translational research with 40+ publications. Education and training are delivered via the International School of Oncoplastic Surgery (ISOS, est. 2014, 1,500+ surgeons trained), a Mastership program with University of East Anglia (UK), the BreastGlobal academic platform, and the RT-PCR research training program (launched Jan 2023).

The business model is donation-funded, with 80G tax-exempt status, corporate sponsorships (Bajaj Auto), and grants; services are free or subsidized at point of use. Leadership comprises Dr. C.B. Koppiker (Founder and Managing Trustee, ~30 years oncosurgical experience) and Ms. Laleh Busheri (CEO, L.L.M, 35+ international and 100+ national research publications). The organization is headquartered in Pune with a single clinical site (Orchids) and a small 14-person core team, operating across Maharashtra with Pan-India reach for screening and training.

Name

Prashanti Cancer Care Mission

Legal name

Prashanti Cancer Care Mission

Website

https://prashanticancercare.org

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

Prashanti Cancer Care Mission (PCCM) is a Pune-based non-profit NGO providing free breast cancer diagnostics, oncoplastic surgery, chemotherapy, radiation, and pharmacy services to underprivileged patients in India, supported by donations, a research biobank, and the ISOS surgical training program.

Ownership category

akta.pro rank

Product category

Breast Cancer Care Services

NAICS

Voluntary Health Organizations (813212), Social Assistance (624), Individual and Family Services (6241)

SIC

Services-Health Services (8000), Services-Social Services (8300)

akta.pro primary industry

Rare Disease & Special Needs Support Organizations (BPAGACAM)

akta.pro secondary industries

Site Identification & Feasibility (HLAGACAB), Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)

Keywords

• Breast cancer care
• Oncoplastic surgery
• Nonprofit healthcare services
• Community cancer screening
• Surgical training programs

Headquarters

HQ city

Pune

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Donations and Charitable Contributions: PCCM operates as a registered NGO established in 1995, relying on donations from individuals, private donors, and organizations. The organization provides tax exemption benefits under Section 80G of Indian tax law (Form 10AC and Form 10BE certificates available to donors).
2. Food Bank Funding: The FoodBank project is funded by private donors and provides food assistance to women in need undergoing breast cancer treatment, addressing nutritional needs of patients and families.
3. Herceptin Fund: PCCM supports patients through the Herceptin (Trastuzumab) Fund for HER-2 positive breast cancer treatment, with approximate total cost of $6000 USD per patient for 1-year treatment. Supported 170+ patients through this fund.
4. Subsidized Services: While core services are free, PCCM provides subsidized genetic testing for breast cancer patients at the Genetic Clinic established in 2017.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels9 records

Core offering

Prashanti Cancer Care Mission is a registered non-profit NGO that provides free and subsidized comprehensive breast cancer care, including diagnostics (mammograms, sonography, biopsies), oncoplastic and reconstructive surgeries, chemotherapy, radiation, pharmacy, genetic counseling, and psychological counseling to underprivileged patients in India. It operates the Orchids Breast Health Center in Pune, runs community awareness and screening camps, and supports a Pink Ribbon Support Group, FoodBank, and Genetic Clinic as part of an integrated care-and-research ecosystem.

Product overview

Prashanti Cancer Care Mission (PCCM) is a healthcare NGO established in 1995 that operates as a unified service model centered on breast cancer care for underprivileged patients in India. The core offering is the freeship program providing comprehensive breast cancer treatment (diagnostics, surgery, chemotherapy, radiation, pharmacy) at no cost. This is supported by Orchids Breast Health Clinic (the first standalone breast cancer center in Pune with state-of-the-art diagnostic equipment), the Pink Ribbon Support Group (patient/caregiver community with 5,000+ members), and the FoodBank Project. PCCM extends its reach through community awareness and screening camps (40,000+ conducted), a Genetic Clinic offering free counseling and subsidized testing, and a specialized Breast Biobank (India's first breast-specific biobank). Research and education capabilities are delivered through the Center for Translational Cancer Research (CTCR) in partnership with IISER Pune, the International School of Oncoplastic Surgery (ISOS), and the BreastGlobal academic platform. The organization also offers webinars and training programs for both patients and medical professionals.

Differentiator

Problem solved

Functional benefit

Brands

• ISOS-PCCM: International School of Oncoplastic Surgery – PCCM initiative offering cutting-edge training programs in Breast Oncoplasty for surgeons across India and abroad.
• Orchids Breast Health Center
• CTCR (Center for Translational Cancer Research)
• Pink Ribbon Support Group
• BreastGlobal
• Prashanti Cancer Care Mission Biobank

Products and services

• Orchids Breast Health Center The first standalone breast cancer centre in the Pune region, offering integrated breast cancer care through oncoplastic surgeons, oncologists, radiation therapists, radiologists, genetic counselors, and nutritionists; equipped with 3D tomosynthesis mammography, VABB machine, automated breast volume scanner, and Mammotome biopsy for screening, diagnosis, and treatment.
• PCCM Genetic Clinic Established in 2017, provides free genetic counseling and subsidized genetic testing for breast cancer patients, along with nutrition, yoga, and psychological counseling services; over 300 patients tested and 500+ patients have received genetic counselling.
• PCCM Breast Biobank India's first specialized breast biobank, established in 2018, comprising an FFPE biobank (1,625+ consented patient samples) and an Indian-origin Fresh Frozen Biobank (100+ samples since November 2022) that supports translational breast cancer research and India-specific treatment evidence.
• International School of Oncoplastic Surgery (ISOS) Founded by Dr. Chaitanyanand Koppiker in 2014 to address gaps in surgical training in Oncoplastic Breast Surgery; offers the Masters in Breast Oncoplasty Program in collaboration with the University of East Anglia (UEA), training surgeons from across India and neighboring nations through online training, webinars, conferences, and workshops.
• BreastGlobal Academic Platform An academic platform established by Dr. Koppiker in collaboration with colleagues to bridge gaps in oncoplastic breast surgery knowledge by providing a single venue where experts, trainees, and industry can access global learning and training opportunities.
• Center for Translational Cancer Research (CTCR) A public-private partnership between IISER Pune and PCCM established to integrate cancer research, training, and education with world-class infrastructure for multidisciplinary research in clinical and translational oncology, including molecular aspects of breast cancer subtypes such as Triple Negative Breast Cancer.
• Freeships in Breast Cancer Treatment End-to-end freeship program covering diagnostics (mammograms, sonography, biopsies), oncoplastic and reconstructive surgeries, chemotherapy, radiation, genetic counseling, psychological counseling, and pharmacy for unaffordable breast cancer patients; 50,000+ patients treated and 2,000+ oncoplastic surgeries performed.
• Pink Ribbon Support Group Support group established in 2009 for breast cancer patients and caregivers, with over 5,000 members; provides emotional support, volunteer assistance at chemotherapy daycare and surgeries, and organizes monthly holistic activities including movies, picnics, breast awareness symposiums, and yoga.
• FoodBank Project Food assistance program providing free nutritious food, fresh produce, grains, supplements, personal hygiene products, and basic utilities to women undergoing breast cancer treatment or recovery; 6,500+ beneficiaries supported.
• Community Awareness and Screening Camps Awareness talks and screening camps conducted across corporates, universities, municipal corporations, mental institutes, police departments, and IT companies; 16,000+ awareness talks and 10,000+ screening sessions conducted, with lumps detected during screening routed to free investigation and treatment.
• Research Training Program for Clinicians and Residents (RT-PCR) Flagship educational initiative of CTCR-PCCM launched in January 2023, providing structured training in cancer biology, translational research, clinical research methodologies, and emerging technologies through online lectures and practical learning, with four modules covering molecular biology, precision medicine, women pioneers in oncology, and evidence synthesis.

Quantifiable outcome

• 50,000+ patients treated with free or subsidized cancer care
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature10 records

Partnerships

Eight partnerships are on record, tiered core, flagship and major.

• IISER Pune (Indian Institute of Science Education and Research)coreStrategic or Co-development Partner · 1 January 2017PCCM and IISER Pune established the Center for Translational Cancer Research (CTCR), a first-of-its-kind initiative in India with world-class infrastructure for multidisciplinary research and training in clinical and translational oncology. This public-private partnership integrates cancer research, training, and education.
• University of East Anglia (UEA)coreStrategic or Co-development Partner · 1 January 2017Collaboration to offer the award-winning Mastership program in Breast Oncoplasty. Dr. Koppiker serves as Associate Professor at UEA and is South-East Asia regional convenor for the program. This is the only course in Asia for cutting-edge Breast Oncoplasty training.
• International School of Oncoplastic Surgery (ISOS)coreStrategic or Co-development Partner · 1 January 2014Founded by Dr. Chaitanyanand Koppiker to fill existing gaps pertaining to surgical training in Oncoplastic Breast Surgery. ISOS trains young and aspiring surgeons from across India and neighbouring nations through online training programs and webinars.
• BreastGlobalflagshipStrategic or Co-development PartnerAcademic platform established by Dr. Koppiker in collaboration with Prof. Chintamani and Dr. Kothari to bridge gaps in knowledge by providing a single platform where experts, trainees and industry can access global learning and training opportunities.
• Society of Oncoplastic Surgery (SOS), USAmajorStrategic or Co-development PartnerDr. Koppiker serves on the board of directors of SOS, USA and has been a visiting faculty. He has been appointed as Joint Editor-in-Chief of the Journal of Oncoplastic Surgery, USA established by SOS.
• Indian Cancer Genome Atlas (ICGA)majorStrategic or Co-development PartnerDr. Koppiker serves on the Board of Directors of ICGA, contributing to national cancer genomics research initiatives.
• Jehangir Hospital, PunecoreStrategic or Co-development PartnerDr. Koppiker serves as Director and heads the Oncosciences Department at Jehangir Hospital, Pune, integrating cancer care services.
• School of Oncoplastic Surgery, USAmajorStrategic or Co-development PartnerMs. Laleh Busheri serves as Member of the Board of Directors for the School of Oncoplastic Surgery, USA, contributing to international surgical education.

Scale indicators14 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@prashanticancercaremission
• LinkedInlinkedin.com/company/prashanti-cancer-care-mission
• Facebookfacebook.com/prashanticancercaremission
• Xx.com/prashanticancerm

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Prashanti Cancer Care Mission